Introduction
============

Laryngeal cancer is a kind of malignant tumor derived from the laryngeal mucosal epithelial tissues ([@b1-etm-0-0-5741]), and its incidence rate accounts for 5% in the incidence rate of systemic tumor and 14.2% in the incidence rate of head-neck tumors ([@b2-etm-0-0-5741]). In the ear-nose-throat filed, laryngeal cancer ranks third following nasopharynx cancer and nasal cancer, and its incidence rate shows an increasing trend, seriously threatening the health and life of patients ([@b3-etm-0-0-5741],[@b4-etm-0-0-5741]). Laryngeal cancer often occurs in people aged 50--70 years, more frequently in males than in females; the proportion of female patients with laryngeal cancer in the Northeast China is higher than that in official reports in China and worldwide. With the rapid development of head-neck tumor surgery, the clinical treatment techniques have been constantly developed and improved, but the prognosis is still not satisfactory ([@b5-etm-0-0-5741]). In order to investigate the related factors affecting the postoperative curative effect on patients with laryngeal cancer, and to develop effective therapeutic regimen and improve the survival rate of patients with laryngeal cancer, the clinical data of 215 patients with laryngeal cancer in the Central Hospital of Wuhan were retrospectively analyzed.

Patients and methods
====================

### General materials

A total of 215 patients with laryngeal cancer admitted in The Central Hospital of Wuhan from May 2010 to May 2017 were selected into the study strictly according to the inclusion and exclusion criteria. Inclusion criteria: patients without radiotherapy and chemotherapy before surgery; patients confirmed as squamous cell carcinoma via cell biopsy; patients with complete data; patients with first-onset cancer and treated in our hospital for the first time. Exclusion criteria: patients with postoperative recurrence of laryngeal cancer; patients who could not receive surgical treatment due to distant metastasis; patient who refused surgical treatment. In the 215 patients with laryngeal cancer, there were 203 males and 12 females aged 41--80 years with an average of 57.2±3.5 years. The vast majority of patients (n=175) had a smoking history, accounting for 81.4%, and approximately 62.3% patients consumed alcohol frequently. Cancer type, there were 95 cases of supraglottic laryngeal cancer, 72 cases of glottic laryngeal cancer and 48 cases of subglottic laryngeal cancer. In terms of tumor differentiation degree, there were 78 cases of high differentiation, 86 cases of moderate differentiation and 51 cases of poor differentiation. According to the latest Union for International Cancer Control (UICC) tumor lymph nodes metastasis (TNM) staging criteria, there were 48 cases of T1 stage, 56 cases of T2 stage, 68 cases of T3 stage and 43 cases of T4 stage. The lymph node (N) stages were 101 cases of N0 stage, 63 cases of N1 stage and 51 cases of N2 stage. The study was approved by the Ethics Committee of The Central Hospital of Wuhan and informed consent was signed by the patients or the guardians.

### Treatment methods

With surgical treatment as the basic treatment measure, all patients received clinical examinations before operation, and underwent total or partial laryngectomy through laryngoscopy and computed tomography/magnetic resonance imaging (CT/MRI) combined with the specific intraoperative situations. Of 215 patients, 148 underwent total laryngectomy, while 67 patients underwent partial laryngectomy. One hundred and forty-four patients received cervical lymph node dissection, while 71 patients did not.

### Follow-up

All patients were followed up via telephone, outpatient return visit, letters, medical data and health insurance card, with the date of operation as the starting point. The survival time began from the date of operation to the date of death, date of loss to follow-up or the last follow-up date.

### Statistical analysis

SPSS 23.0 software (SPSS Inc., Chicago, IL, USA) was used for the data processing and analysis. The survival rate was calculated using Kaplan-Meier method, and the survival curve was drawn. Log-rank test was used for single-factor analysis, while Cox proportional hazard regression model was used for multiple-factor analysis. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Follow-up results and survival rates

All of the 215 patients were followed up, and the 5-year follow-up rate was 100%. There were 16 cases of survival without tumor, 10 cases of survival with tumor and 41 cases of death, among which 21 cases died of laryngeal cancer recurrence, 2 cases died of lung metastasis, 1 case died of cervical metastasis, 4 cases died of heart disease and 13 cases died due to unknown causes. The 1-, 3- and 5-year survival rates were 96.2, 78.0 and 72.5%, respectively, and the survival curve is shown in [Fig. 1](#f1-etm-0-0-5741){ref-type="fig"}.

### Single-factor analysis of postoperative curative effect on patients with laryngeal cancer

The results of single-factor analysis showed that the age, primary tumor site, tumor differentiation degree, T stage, N stage, smoking index, tumor diameter and lymph node metastasis had significant influences on the postoperative curative effect on patients (P\<0.05), but the patient\'s age, drinking habit and surgical method had no significant correlation with the postoperative curative effect (P\>0.05) ([Table I](#tI-etm-0-0-5741){ref-type="table"}).

### Multiple-factor analysis of surgical effect on patients with laryngeal cancer

Cox proportional hazard regression model was used for multiple-factor analysis with the age, primary tumor site, tumor differentiation degree, T stage, N stage, smoking index, tumor diameter and lymph node metastasis in the single-factor analysis were included, and the results showed that the primary tumor site, T stage, N stage and lymph node metastasis were the independent risk factors affecting the surgical effect on patients with laryngeal cancer (P\<0.05) ([Table II](#tII-etm-0-0-5741){ref-type="table"}). In order to show the difference in survival rate among the four independent prognostic factors, the survival curves were drawn ([Figs. 2](#f2-etm-0-0-5741){ref-type="fig"}--[5](#f5-etm-0-0-5741){ref-type="fig"}).

Discussion
==========

Laryngeal cancer is one of the common malignant tumors in the head and neck, and its incidence rate still shows an upward trend. Although progress has been made constantly in the clinical comprehensive treatment, surgery, biotherapy and genetic research, and the diagnosis and treatment of patients with laryngeal cancer are improved, its survival rate shows a downward trend ([@b6-etm-0-0-5741]); therefore, the understanding of factors affecting the prognosis of patients, and appropriate prognosis estimation and clinical treatment are of great significance in improving the survival rate of patients with laryngeal cancer. Compared with other studies, the subjects were selected in this study in strict accordance with the inclusion and exclusion criteria for seven years, thus ensuring the credibility of results.

The results of single-factor analysis showed that the age was an important factor affecting the patient\'s postoperative efficacy. This study revealed that the survival rate was 35.2% in patients with laryngeal cancer aged over 57 years and 73.0% in patients aged 57 years and below. The poorer prognosis in elderly patients than that in middle-aged patients may be caused by the following factors: the human natural resistance and the function of various organs are weakened with age; the failure of various organs lead to other types of disease and increase the mortality rate; after surgery and a series of treatment, the body function of the elderly patients is damaged, and the absorption and recovery rates are slow.

Swisher-McClure *et al* ([@b7-etm-0-0-5741]) reported that the body function declines with the age in patients with laryngeal cancer, resulting in poorer prognosis than those in the middle-aged patients than those in the middle-aged patients, and it is a potential risk factor of poor prognosis. The sex has no significant correlation with the postoperative efficacy on patients, the middle-aged men are dominant in patients with laryngeal cancer, and the incidence rate of laryngeal cancer in men is much higher than that in women, which is consistent with our research (203 male patients and 12 female patients, 17:1). The study of Guo *et al* ([@b8-etm-0-0-5741]) showed that the sex is one of the important factors affecting the prognosis of laryngeal cancer, but there was no significant correlation between sex and prognosis of laryngeal cancer in this study, and the specific influencing mechanism needs to be further explored. The smoking index is also associated with the postoperative efficacy on patients. The smoke in tobacco and tobacco burning contains many carcinogenic substances, and smoking has always been recognized as the most important risk factor of lung cancer ([@b9-etm-0-0-5741]). In the single-factor analysis, smoking also had a statistically significant effect on the postoperative efficacy on patients with laryngeal cancer.

The study of Kim *et al* ([@b10-etm-0-0-5741]) showed that the survival rate of smokers with laryngeal cancer is only one third of that of non-smokers, so smoking is an important factor affecting the prognosis of patients. In this study, both single-factor analysis and multiple-factor analysis revealed that the primary tumor site, T stage, N stage and lymph node metastasis were independent risk factors for the prognosis of patients with laryngeal cancer. Our data showed that the prognosis of patients with supraglottic cancer was superior to that of patients with glottic cancer and subglottic cancer; however, de Miguel-Luken *et al* ([@b11-etm-0-0-5741]) stated that the prognosis of patients with glottic cancer is better than that of patients with supraglottic cancer, because there are rich lymphatic vessels above the vocal cords, and lymphatic metastasis occurs easily in the tumor in this site with high occult metastasis ([@b12-etm-0-0-5741]). It is thought that the early symptoms of supraglottic cancer can affect the throat and pharynx, and patients will seek medical treatment once uncomfortable, which has no significant correlation with its prognosis (P\>0.05); the different conclusions need further study.

It is believed that the higher the T stage and N stage are, the lower the survival rate of patients will be. The higher T stage indicates larger tumor size and involved range, increased lymph node metastasis rate, more damaged sites, difficult combined cure and decreased survival rate. However, Han and Ge ([@b13-etm-0-0-5741]) reported that the higher T stage decreases the survival rate of patients with laryngeal cancer, but it is not an independent influencing factor of prognosis. The N stage represents the lymph node metastasis staging of tumor, and the survival rate of patients with lymph node metastasis-positive laryngeal cancer is significantly lower than that of patients with lymph node metastasis-negative laryngeal cancer; moreover, the higher the N stage is, the lower the survival rate will be. The higher the tumor differentiation degree is, the malignant degree will be, reducing the survival rate of patients. Besides, the tumor diameter can reflect the tumor development time and deterioration degree indirectly, which has a significant impact on the survival rate of patients.

The study of Liu *et al* ([@b14-etm-0-0-5741]) came to the same conclusion as our study. In this study, the treatment method was not an influencing factor of prognosis, which was different from the conclusion made by Zhang *et al* ([@b15-etm-0-0-5741]), maybe because the different types of patients affect the experimental results. Zhang *et al* ([@b15-etm-0-0-5741]) thought that the correct treatment method is important for the recurrence of laryngeal cancer, the survival rate of patients receiving comprehensive treatment is higher than that of patients receiving simple surgical treatment, and the tumor can be radically cured via the combined application of radiotherapy and chemotherapy after surgical resection, greatly increasing the survival rate of patients.

In the latest study, the research on the pathogenesis and prognosis of laryngeal cancer has been developed to the levels of gene and blood type. Choe *et al* ([@b16-etm-0-0-5741]) reported that the STAT3 gene expression in laryngeal cancer cells is related to the prognosis of patients. Jin *et al* ([@b17-etm-0-0-5741]) considered that the ABO blood type can predict the survival rate of patients with laryngeal cancer, and the survival rate of patients with O blood type is lower than that with other types. Moreover, Dang *et al* ([@b18-etm-0-0-5741]) argued that mitochondrial DNA (mtDNA) can predict the prognosis of patients with early laryngeal cancer. These cutting-edge research directions may guide the researchers to obtain different diagnosis and quality treatment methods of laryngeal cancer.

In conclusion, we believe that the age, primary tumor site, tumor differentiation degree, T stage, N stage, smoking index, tumor diameter and lymph node metastasis are the factors affecting the surgical treatment effect on patients with laryngeal cancer. The independent factors affecting the prognosis of patients with laryngeal cancer are the primary tumor site, T stage, N stage and lymph node metastasis. Patients with laryngeal cancer should be diagnosed and treated in time, the laryngeal function should be retained as far as possible in the case of complete resection of tumor, and the surgical treatment should be combined with other treatment means, so as to improve the survival rate of patients with laryngeal cancer.
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![Postoperative survival curve of 215 patients with laryngeal cancer. It can be seen that the survival rate of patients with laryngeal cancer is decreased with time.](etm-15-03-2786-g00){#f1-etm-0-0-5741}

![Postoperative survival curves of patients with different primary tumor sites. It can be seen that the survival rate of patients with supraglottic laryngeal cancer is higher than that of patients with glottic and subglottic cancers. The Kaplan-Meier method shows that the 1-, 3- and 5-year survival rates of patients with supraglottic laryngeal cancer are 95.4, 89.5 and 72.6%, respectively. The 1-, 3- and 5-year survival rates of patients with glottic laryngeal cancer are 92.8, 88.9 and 58.3%, respectively. The 1-, 3- and 5-year survival rates of patients with subglottic laryngeal cancer are 86.4, 70.8 and 22.9%, respectively.](etm-15-03-2786-g01){#f2-etm-0-0-5741}

![Survival curves of patients with different T stages. The survival rates of patients in T1 and T2 stages are significantly higher than those in T3 and T4 stages.](etm-15-03-2786-g02){#f3-etm-0-0-5741}

![Survival curves of patients with different N stages. It can be seen that the survival rate of patients with laryngeal cancer in N0 stage is significantly higher than that in N1 and N2 stages; the 1-, 3- and 5-year survival rates of patients with laryngeal cancer in N0 stage are 95.4, 87.1 and 76.5%, respectively. The 1-, 3- and 5-year survival rates of patients with laryngeal cancer in N1 stage are 69.5, 58.7 and 49.4%, respectively. The 1-, 3- and 5-year survival rates of patients with laryngeal cancer in N2 stage are 56.4, 45.1 and 31.0%, respectively.](etm-15-03-2786-g03){#f4-etm-0-0-5741}

![Survival curves of patients with lymph node metastasis. The survival rate of lymph node metastasis-negative patients is significantly higher than that of lymph node metastasis-positive patients. The 1-, 3- and 5-year survival rates of lymph node metastasis-positive patients are 73.9, 68.8 and 24.5%, respectively.](etm-15-03-2786-g04){#f5-etm-0-0-5741}

###### 

Single-factor analysis of postoperative curative effect on 215 patients with laryngeal cancer.

  Characteristics                  n              3-year survival rate   5-year survival rate   Log-rank value   P-value
  -------------------------------- -------------- ---------------------- ---------------------- ---------------- ---------
  Sex                                                                                           1.265            0.495
    Male                           203 (94.4%)    81.4%                  73.1%                                   
    Female                         12 (5.6%)      79.6%                  71.2%                                   
  Age                                                                                           7.518            0.038
    \>57                           139 (64.7%)    65.5%                  35.2%                                   
    ≤57                              76 (35.3%)   82.5%                  73.0%                                   
  Smoking index (pcs/year)                                                                      7.658            0.029
    \<400                            32 (14.9%)   85.5%                  79.4%                                   
    ≥400, \<800                    101 (47.0%)    72.0%                  53.5%                                   
    ≥800                             82 (38.1%)   64.6%                  43.6%                                   
  Primary tumor site                                                                            19.587           \>0.05
    Supraglottic type                95 (44.2%)   89.5%                  72.6%                                   
    Glottic type                     72 (33.5%)   88.9%                  58.3%                                   
    Subglottic type                  48 (22.3%)   70.8%                  22.9%                                   
  Tumor differentiation degree                                                                  18.594           0.002
    High differentiation             78 (36.3%)   88.5%                  81.2%                                   
    Moderate differentiation         86 (40.0%)   75.6%                  67.5%                                   
    Poor differentiation             51 (23.7%)   45.1%                  43.7%                                   
  T stage                                                                                       17.613           0.013
    T1                               48 (22.3%)   91.7%                  88.4%                                   
    T2                               56 (26.0%)   82.1%                  79.6%                                   
    T3                               68 (31.6%)   61.8%                  42.1%                                   
    T4                               43 (20.0%)   60.5%                  40.7%                                   
  N stage                                                                                       19.142           \>0.05
    N0                             101 (47.0%)    87.1%                  76.5%                                   
    N1                               63 (29.3%)   58.7%                  49.4%                                   
    N2                               51 (23.7%)   45.1%                  31.0%                                   
  Drinking                                                                                      1.505            0.220
    Never or occasionally            81 (37.7%)   82.7%                  75.9%                                   
    Often                          134 (62.3%)    73.1%                  65.7%                                   
  Tumor diameter (cm)                                                                           19.783           \>0.05
    ≤2                             106 (49.3%)    82.1%                  76.1%                                   
    \>2, ≤4                          68 (31.6%)   77.9%                  49.8%                                   
    \>4                              41 (19.1%)   70.7%                  35.7%                                   
  Surgical method                                                                               6.121            0.059
    Total laryngectomy             148 (68.8%)    84.5%                  60.9%                                   
    Partial laryngectomy             67 (31.2%)   76.1%                  68.4%                                   
  Lymph node metastasis                                                                         25.105           \>0.05
    Positive                         46 (21.4%)   68.8%                  24.5%                                   
    Negative                       169 (78.6%)    95.3%                  79.6%                                   
  Cervical lymph node dissection                                                                3.172            0.17
    No                               71 (33.0%)   75.9%                  58.5%                                   
    Functional                       63 (29.3%)   85.7%                  64.9%                                   
    Radical                          81 (37.7%)   93.8%                  76.8%                                   

###### 

Multiple-factor analysis of surgical effect on 215 patients with laryngeal cancer.

  Influencing factor      β value   SE      Wald     P-value   Hazard ratio (HR)   95% confidence interval (CI)
  ----------------------- --------- ------- -------- --------- ------------------- ------------------------------
  Primary tumor site      1.315     0.368   10.526   0.001     3.618               1.592--7.925
  T stage                 1.259     0.540   5.426    0.019     3.522                 1.221--10.159
  N stage                 0.699     0.321   3.200    0.040     2.012               1.031--3.926
  Lymph node metastasis   1.152     0.358   4.125    0.028     2.916               1.151--4.581
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